Skip to main content
Simon Barquera on Muck Rack

Simon Barquera

As seen in: Color Research & Application, El País, Nature, Environment and Behavior, PLOS Medicine, PLOS ONE, MDPI, Milenio, The BMJ, Globalization and Health and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Simon

Contact Simon, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Health partnerships risk legitimising harmful industries

|
By Simon Barquera, Angela Carriedo, Kent Buse
| The BMJ Verified
News & Views Health partnerships... Health partnerships risk legitimising harmful industries Opinion BMJ 2026; 393 doi: https://doi.org/10.1136/bmj.s629 Cite this as: BMJ 2026;393:s629 Simon Barquera, director, Angela Carriedo, lecturer, Kent Buse, professor of health policy Author affiliations The Pan American Health Organization’s partnership with Ferrero is yet another example of questionable corporate tactics, write Simon Barquera, Angela Carriedo, and Kent Buse.
Open in Who Shared Issue with article?

Author Correction: Governance and resilience as entry points for transforming food systems in the countdown to 2030 - Nature Food

|
By Kate Schneider Verified, Roseline Remans, Tesfaye Hailu Bekele, Shouro Dasgupta, Fabrice DeClerck, Deviana Dewi, Carola Fabi, Jessica A. Gephart, Yuta J. Masuda, Rebecca McLaren, Nancy J. Aburto, Ramya Ambikapathi, Mariana Rodriguez, Simon Barquera, Jane Battersby, Ty Beal, Christophe Béné, Carlo Cafiero, Patrick Caron, Andrea Cattaneo, Jeroen Candel, Namukolo Covic, Ismahane Elouafi, Tyler J. Frazier, Alexander K. Fremier, Pat Foley, Christopher Golden, Carlos Fischer, Alejandro Guarin, Sheryl L Hendriks, Anna Herforth, Maddalena Honorati, Jikun Huang, Yonas Getaneh, Gina Kennedy, Amos Laar, Rattan Lal, Preetmoninder Lidder, Brent Loken, Hazel Malapit, Quinn Marshall, Kalkidan Mulatu, Ana Munguía, Stella Nordhagen, Danielle Resnick, Diana Suhardiman, U. Rashid Sumaila, Bangyao Sun, Máximo Torero Cullen, Francesco N. Tubiello, Corné van Dooren, Isabel Morales, Jose-Luis Vivero-Pol, Patrick Webb, Keith Wiebe, Lawrence Haddad, Mario Herrero, José Rosero Moncayo, Jessica Fanzo, Destan Aytekin, Piero Conforti, Michaela Saisana, Christine Campeau, Belay Terefe Mengesha
| Nature Verified
Correction to: Nature Food https://doi.org/10.1038/s43016-024-01109-4, published online 14 January 2025. In the version of this article initially published, the affiliation shown for Isabel Valero Morales was incorrect. The affiliation should have appeared as “Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.” The error has been corrected in the HTML and PDF versions of the article.
Open in Who Shared Issue with article?

Opinion: The liver - a metabolic health blindspot on the global NCD agenda

|
By Jeffrey V. Lazarus, Peter Schwarz, Simon Barquera
| Devex
At a time when the burden of noncommunicable diseases, or NCDs, is climbing relentlessly, overlooking a condition that strikes more than 1 in 3 adults — despite available solutions — is indefensible. Chronic liver disease, or CLD, is a public health threat at the very core of the NCD crisis — especially due to metabolic dysfunction-associated steatotic liver disease, or MASLD (formerly called nonalcoholic fatty liver disease, or NAFLD), and its more advanced form, MASH.
Open in Who Shared Issue with article?
See all 32 licensed articles (37 Total)